StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 10/10/2013 -- StockRunway.com issues special report on – Minerco Resources Inc(OTCMKTS:MINE), Bullfrog Gold Corp(OTCMKTS:BFGC), RXi Pharmaceuticals Corp(OTCMKTS:RXII), CVSL Inc(OTCMKTS:CVSL)
Minerco Resources Inc(OTCMKTS:MINE) stock is at $0.0032, down -13.51 percent from its previous close of $0.0037. The stock opened the session at $0.0035 and touched its highest price point at $0.0035.
Stocks graphical chart shows a bearish trend during its last one month’s trading session. It remained positive with +146.15% during previous three months trade. Its recent trading volume was 33.97 million shares in comparison to its usual trading volume of 30.84 million shares. Minerco Resources, Inc., a development stage company, engages in the development, production, and provision of clean, renewable energy solutions in Central America.
Has MINE Found The Bottom and Ready To Move Up? Find Out Here
Bullfrog Gold Corp(OTCMKTS:BFGC) stock is at $0.180, down -13.04 percent from its previous close of $0.207. Its today’s volume is 1.27 million shares in comparison to its usual trading volume of 527,741.00 shares. The stock opened the session at $0.20 and touched its highest price point at $0.20.
BFGC’s quarterly performance remained red with the percentage of -10, while its year to date performance showed that the stock plunged overall -51.35%. Bullfrog Gold Corp., a junior exploration company, engages in the acquisition and exploration of gold properties in the United States.
Has BFGC Found The Bottom And Ready To Gain Momentum? Find Out Here
RXi Pharmaceuticals Corp(OTCMKTS:RXII) experienced a plunge of -12.98 % to a market valuation of $34.47M per share for previous trading session. After opening the day at $3.29 per share, volume surged to 129,817.00 .
During last one month it slipped with the percentage of -19.18. Its year to date performance remained progressive with +33833.33%. RXi Pharmaceuticals Corporation discovers, develops, and commercializes therapies based on its RNAi platform. It provides RXI-109, a self-delivering RNAi compound (sd-rxRNA) for the reduction of dermal scarring in planned surgeries, as well as reduces the expression of connective tissue growth factor, a critical regulator of several biological pathways involved in fibrosis, including scar formation in the skin. The company was founded in 2011 and is based in Worcester, Massachusetts. RXi Pharmaceuticals Corporation operates as a subsidiary of Galena Biopharma, Inc.
Why Should Investors Buy RXII After the Recent Fall? Just Go Here and Find Out
CVSL Inc(OTCMKTS:CVSL) opened its shares at the price of $0.72 for the day, its closing price was $0.680 after losing -12.83% for the day. The company traded with the total volume of 343,772.00 shares while its average trading aptitude remained 52,796.00 shares. The company has total of 487.71 million outstanding shares and its total market capitalization is $331.60 million. CVSL Inc. primarily operates in the direct-selling business in the United States. The company, through its subsidiary, The Longaberger Company, sells hand-crafted baskets and a line of products for the home, including pottery, cookware, wrought iron, and other home décor products through a network of independent sales representatives.
Will CVSL Get Buyers Even After The Recent Rally? Find Out Here
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)